HTA Board - 29 June 2023
Human Tissue Authority Board Meeting Conducted in Public
Human Tissue Authority Board Meeting Conducted in Public
To complement our sector-focused stakeholder forums we have a programme of roundtables.
The round-tables are intended to enable the HTA to:
The most recent blogs about the round tables can be found here:
This guidance helps licensed establishments to meet the HTA’s research licensing standards. The documents contain additional information and examples of how to meet certain standards.
Nicolette Harrison, Director of Regulations, talks about the role inspections play in a risk-based, proportionate, data-driven, modern regulator.
HTA Business Plan for 2023 to 2024 published
Our Business Plan sets out our priorities for the business year 2023 to 2024.
Last month we held three more sector focused forums. Meeting together in this way has many benefits, as some of the things we talked about can illustrate.
The purpose of this guidance is to assist licensed establishments to meet the HTA’s licensing standards. The documents contain additional information and examples of how to meet certain Standards.
We recently started a new programme of sector-focused stakeholder engagement forums starting with leaders from the Human Application, ODT, Anatomy and Post Mortem sectors, where the Terms of Reference were agreed. We’re looking forward to further forums later in the year.
The forums have three functions:
to provide a forum to discuss sector-focused regulatory issues
to consider regulatory policies and practice
to share relevant regulatory concerns, knowledge, insight, and intelligence.